Lupus Foundation of America1d
Investigator-initiated Study of CNTY-101, for People with Autoimmune Diseases, Including Systemic Lupus Erythematosus and Lupus Nephritis Announced
An investigator-initiated Phase 1/2 trial of CNTY-101, an investigational therapy, has been announced for the treatment of ...
Lupus Foundation of America3d
New Study Identifies Predictors of Successful Glucocorticoid Discontinuation in Systemic Lupus Erythematosus Treatment
A new study found that low or absent disease activity, hydroxychloroquine (HCQ) use, and gradual reduction of GC dosing can ...
Lupus Foundation of America3d
Community Cares Southeast Region | Southeast
Community Cares are individuals, organizations, and companies who are helping us to solve the cruel mystery of lupus by raising awareness and funds in their community. Together, we are working to ...